{"parse":{"title":"Attention deficit hyperactivity disorder predominantly inattentive","pageid":4081458,"revid":860028931,"text":{"*":"<div class=\"mw-parser-output\"><p class=\"mw-empty-elt\">\n</p>\n<table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background:#ccc\">Attention deficit hyperactivity disorder predominantly inattentive</th></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#eee;;\">Classification and external resources</th></tr><tr class=\"noprint\"><td colspan=\"2\" style=\"text-align:center\">\n<div style=\"text-align: right; font-size:0.9em;\">[<a href=\"https://www.wikidata.org/wiki/Q1993146\" class=\"extiw\" title=\"d:Q1993146\">edit on Wikidata</a>]</div></td></tr></tbody></table>\n<p><b>Attention deficit hyperactivity disorder predominantly inattentive</b> (<b>ADHD-PI</b> or <b>ADHD-I</b>),<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup> is one of the three presentations of <a href=\"/wiki/Attention_deficit_hyperactivity_disorder\" title=\"Attention deficit hyperactivity disorder\">attention deficit hyperactivity disorder</a> (ADHD).<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> It was formerly known as <b>attention deficit disorder (without hyperactivity)</b>, but the term was formally changed in 1994 in the <i><a href=\"/wiki/Diagnostic_and_Statistical_Manual_of_Mental_Disorders\" title=\"Diagnostic and Statistical Manual of Mental Disorders\">Diagnostic and Statistical Manual of Mental Disorders</a></i>, fourth edition (<i>DSM-IV</i>), to \"ADHD predominantly inattentive\" (ADHD-PI).<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\n</p><p>The 'predominantly inattentive subtype' is similar to the other presentations of ADHD except that it is characterized primarily by problems with inattention or a deficit of sustained attention, such as procrastination, hesitation, and forgetfulness. It differs in having fewer or no typical symptoms of <a href=\"/wiki/Hyperactivity\" class=\"mw-redirect\" title=\"Hyperactivity\">hyperactivity</a> or impulsiveness. <a href=\"/wiki/Fatigue_(medical)\" class=\"mw-redirect\" title=\"Fatigue (medical)\">Lethargy and fatigue</a> are sometimes reported, but ADHD-PI is a separate condition from the proposed cluster of symptoms known as <a href=\"/wiki/Sluggish_cognitive_tempo\" title=\"Sluggish cognitive tempo\">sluggish cognitive tempo</a> (SCT).\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Classification\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Classification</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Signs_and_symptoms\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Signs and symptoms</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#DSM-5_criteria\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">DSM-5 criteria</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Treatment\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Treatment</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Medication\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Medication</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Prognosis\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Prognosis</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Self-esteem\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">Self-esteem</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Coping_and_age\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Coping and age</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Comparisons_between_subtypes\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">Comparisons between subtypes</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#Epidemiology\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Epidemiology</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#History\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#References\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Classification\">Classification</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=1\" title=\"Edit section: Classification\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>ADHD-PI is an attention-concentration deficit that has everything in common with other forms of ADHD except that it has fewer <a href=\"/wiki/Hyperactivity\" class=\"mw-redirect\" title=\"Hyperactivity\">hyperactivity</a> or <a href=\"/wiki/Impulsivity\" title=\"Impulsivity\">impulsivity</a> symptoms and has more <a href=\"/wiki/Directed_attention_fatigue\" title=\"Directed attention fatigue\">directed attention fatigue</a> symptoms.<sup id=\"cite_ref-add_college_5-0\" class=\"reference\"><a href=\"#cite_note-add_college-5\">&#91;5&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Signs_and_symptoms\">Signs and symptoms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=2\" title=\"Edit section: Signs and symptoms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"DSM-5_criteria\">DSM-5 criteria</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=3\" title=\"Edit section: DSM-5 criteria\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The <a href=\"/wiki/DSM-5\" title=\"DSM-5\">DSM-5</a> allows for diagnosis of the <i>predominantly inattentive</i> presentations of ADHD (code 314.00) if the individual presents six or more (five for adults) of the following symptoms of inattention for at least six months to a point that is disruptive and inappropriate for developmental level:\n</p>\n<ul><li>Often does not give close attention to details or makes careless mistakes in schoolwork, work, or other activities.</li>\n<li>Often has trouble keeping attention on tasks or play activities.</li>\n<li>Often does not seem to listen when spoken to directly.</li>\n<li>Often does not follow instructions and fails to finish schoolwork, chores, or duties in the workplace (not due to oppositional behavior or failure to understand instructions).</li>\n<li>Often has trouble organizing activities.</li>\n<li>Often avoids, dislikes, or doesn't want to do things that take a lot of mental effort for a long period (such as schoolwork or homework).</li>\n<li>Often loses things needed for tasks and activities (e.g. toys, school assignments, pencils, books, or tools).</li>\n<li>Is often easily distracted.</li>\n<li>Is often forgetful in daily activities.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup></li></ul>\n<p>An ADHD diagnosis is contingent upon the symptoms of impairment presenting themselves in two or more settings (e.g., at school or work and at home). There must also be clear evidence of clinically significant impairment in social, academic, or occupational functioning. Lastly, the symptoms must not occur exclusively during the course of a <a href=\"/wiki/Pervasive_developmental_disorder\" title=\"Pervasive developmental disorder\">pervasive developmental disorder</a>, <a href=\"/wiki/Schizophrenia\" title=\"Schizophrenia\">schizophrenia</a>, or other <a href=\"/wiki/Psychotic_disorder\" class=\"mw-redirect\" title=\"Psychotic disorder\">psychotic disorder</a>, and are not better accounted for by another mental disorder (e.g., <a href=\"/wiki/Mood_disorder\" title=\"Mood disorder\">mood disorder</a>, <a href=\"/wiki/Anxiety_disorder\" title=\"Anxiety disorder\">anxiety disorder</a>, <a href=\"/wiki/Dissociative_disorder\" title=\"Dissociative disorder\">dissociative disorder</a>, <a href=\"/wiki/Personality_disorder\" title=\"Personality disorder\">personality disorder</a>).<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (October 2016)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<table class=\"plainlinks metadata ambox mbox-small-left ambox-content ambox-Unreferenced\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>does not <a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\">cite</a> any <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">sources</a></b>.  <small><i>(October 2016)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"wikitable\">\n<tbody><tr>\n<th>Life Period\n</th>\n<th>Examples of Observed Symptoms\n</th></tr>\n<tr>\n<td rowspan=\"9\">Children\n</td>\n<td>Failing to pay close attention to details or making careless mistakes when doing school-work or other activities\n</td></tr>\n<tr>\n<td>Trouble keeping attention focused during play or tasks\n</td></tr>\n<tr>\n<td>Appearing not to listen when spoken to (often being accused of \"daydreaming\")\n</td></tr>\n<tr>\n<td>Failing to follow instructions or finish tasks\n</td></tr>\n<tr>\n<td>Avoiding tasks that require a high amount of longer-term mental effort and organization, such as school projects\n</td></tr>\n<tr>\n<td>Frequently losing items required to facilitate tasks or activities, such as school supplies\n</td></tr>\n<tr>\n<td>Excessive distractibility\n</td></tr>\n<tr>\n<td>Forgetfulness\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Procrastination\" title=\"Procrastination\">Procrastination</a>, inability to begin an activity, such as completing homework\n</td></tr>\n<tr>\n<td colspan=\"2\">\n</td></tr>\n<tr>\n<td rowspan=\"16\">Adults\n</td>\n<td><a href=\"/wiki/Procrastination\" title=\"Procrastination\">Procrastination</a>; delaying or avoiding starting projects that require <a href=\"/wiki/Attentional_control\" title=\"Attentional control\">vigilant</a> mental effort\n</td></tr>\n<tr>\n<td>Difficulty <a href=\"/wiki/Attentional_control\" title=\"Attentional control\">sustaining concentration</a> on conversations or briefly losing attention on someone speaking\n</td></tr>\n<tr>\n<td>Hesitation to <a href=\"/wiki/Attentional_control\" title=\"Attentional control\">sustain concentration</a> in planning and organizing for the completion of tasks\n</td></tr>\n<tr>\n<td>Hesitative responses, doubt, and delayed execution due to inattention <a href=\"/wiki/Recall_(memory)\" title=\"Recall (memory)\">remembering</a> information\n</td></tr>\n<tr>\n<td>Difficulty finishing projects or completing assignments because many tasks simultaneously on the go\n</td></tr>\n<tr>\n<td>Forgetting to complete tasks and details after temporarily switching to more stimulating tasks\n</td></tr>\n<tr>\n<td>Difficulty finding misplaced tools after task switching due to bypassing adequate <a href=\"/wiki/Recall_(memory)\" title=\"Recall (memory)\">memory</a> storage\n</td></tr>\n<tr>\n<td>Sustained information processing is slower than others causing information gaps that inhibit execution\n</td></tr>\n<tr>\n<td>Problems <a href=\"/wiki/Recall_(memory)\" title=\"Recall (memory)\">remembering</a> appointments, obligations, or instructions\n</td></tr>\n<tr>\n<td>Difficulty learning new projects when <a href=\"/wiki/Attentional_control\" title=\"Attentional control\">concentration</a> deficits cause desire to <a href=\"/wiki/Human_multitasking\" title=\"Human multitasking\">multitask</a> or <a href=\"/wiki/Daydreaming\" class=\"mw-redirect\" title=\"Daydreaming\">daydream</a>\n</td></tr>\n<tr>\n<td>Distracted from persevering during work; difficulty holding onto a job for a significant amount of time\n</td></tr>\n<tr>\n<td>Change plans to the inconvenience of others due to <a href=\"/wiki/Recall_(memory)\" title=\"Recall (memory)\">forgetting</a> or not fully aware of the bigger scenario\n</td></tr>\n<tr>\n<td>Maintaining excessive personal items such as storing old items of diminished usefulness\n</td></tr>\n<tr>\n<td><a href=\"/wiki/Intrusive_thoughts\" class=\"mw-redirect\" title=\"Intrusive thoughts\">Obsessive</a> behavior as <a href=\"/wiki/Compensation_(psychology)\" title=\"Compensation (psychology)\">compensation</a> or <a href=\"/wiki/Coping_(psychology)\" title=\"Coping (psychology)\">coping</a> mechanism for a perseverance deficit\n</td></tr>\n<tr>\n<td>Difficulty transitioning to new task or activity due to <a href=\"/wiki/Intrusive_thoughts\" class=\"mw-redirect\" title=\"Intrusive thoughts\">obsessive</a> behavior\n</td></tr>\n<tr>\n<td>Higher rate of <a href=\"/wiki/Vigilance_(psychology)\" title=\"Vigilance (psychology)\">vigilant</a> <a href=\"/wiki/Directed_attention_fatigue\" title=\"Directed attention fatigue\">concentration fatigue</a> after <a href=\"/wiki/Cognitive_inhibition\" title=\"Cognitive inhibition\">inhibiting many distractions</a> from greater effort required\n</td></tr></tbody></table>\n<h2><span class=\"mw-headline\" id=\"Treatment\">Treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=4\" title=\"Edit section: Treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Attention_deficit_hyperactivity_disorder_management\" title=\"Attention deficit hyperactivity disorder management\">Attention deficit hyperactivity disorder management</a></div>\n<p>Although ADHD has most often been treated with medication, medications do not cure ADHD. They are used solely to treat the symptoms associated with this disorder and the symptoms will come back once the medication stops.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Medication\">Medication</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=5\" title=\"Edit section: Medication\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Stimulants are typically formulated in fast and slow-acting as well as short and long-acting formulations. The fast-acting <a href=\"/wiki/Amphetamine_mixed_salts_(medication)\" class=\"mw-redirect\" title=\"Amphetamine mixed salts (medication)\">amphetamine mixed salts</a> (Adderall) and its derivatives, with short and long-acting formulations bind to the <a href=\"/wiki/Trace_amine_associated_receptor_1\" class=\"mw-redirect\" title=\"Trace amine associated receptor 1\">trace amine associated receptor</a> and triggers the release of dopamine into the <a href=\"/wiki/Synaptic_cleft\" class=\"mw-redirect\" title=\"Synaptic cleft\">synaptic cleft</a>.<sup id=\"cite_ref-junginger_8-0\" class=\"reference\"><a href=\"#cite_note-junginger-8\">&#91;8&#93;</a></sup> They may have a better <a href=\"/wiki/Cardiovascular_disease\" title=\"Cardiovascular disease\">cardiovascular disease</a> profile than methylphenidate and potentially better tolerated.<sup id=\"cite_ref-kolar_9-0\" class=\"reference\"><a href=\"#cite_note-kolar-9\">&#91;9&#93;</a></sup>\n</p><p>The fast-acting <a href=\"/wiki/Methylphenidate\" title=\"Methylphenidate\">methylphenidate</a> (Ritalin), is a dopamine reuptake inhibitor.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup> In the short term, <a href=\"/wiki/Methylphenidate\" title=\"Methylphenidate\">methylphenidate</a> is well tolerated. However, long term studies have not been conducted in adults and concerns about increases in blood pressure have not been established.<sup id=\"cite_ref-Safety_of_therapeutic_methylphenidate_in_adults:_a_systematic_review_of_the_evidence_11-0\" class=\"reference\"><a href=\"#cite_note-Safety_of_therapeutic_methylphenidate_in_adults:_a_systematic_review_of_the_evidence-11\">&#91;11&#93;</a></sup>\n</p><p>The slow and long-acting nonstimulant <a href=\"/wiki/Atomoxetine\" title=\"Atomoxetine\">atomoxetine</a> (Strattera), is primarily a <a href=\"/wiki/Norepinephrine_reuptake_inhibitor\" title=\"Norepinephrine reuptake inhibitor\">norepinephrine reuptake inhibitor</a> and, to a lesser extent, a <a href=\"/wiki/Dopamine_reuptake_inhibitor\" title=\"Dopamine reuptake inhibitor\">dopamine reuptake inhibitor</a>. It may be more effective for those with predominantly inattentive concentration.<sup id=\"cite_ref-atom_12-0\" class=\"reference\"><a href=\"#cite_note-atom-12\">&#91;12&#93;</a></sup> It is sometimes prescribed in adults who do not get enough <a href=\"/wiki/Vigilance_(psychology)\" title=\"Vigilance (psychology)\">vigilant</a> <a href=\"/wiki/Attentional_control\" title=\"Attentional control\">concentration</a> response from <a href=\"/wiki/Mixed_Amphetamine_Salts\" class=\"mw-redirect\" title=\"Mixed Amphetamine Salts\">mixed amphetamine salts</a> (Adderall) or get too many side effects.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources_(medicine)\" title=\"Wikipedia:Identifying reliable sources (medicine)\"><span title=\"Material near this tag may rely on an unreliable or less reliable medical source. (October 2016)\">unreliable medical source</span></a></i>&#93;</sup> It is also approved for <a href=\"/wiki/ADHD\" class=\"mw-redirect\" title=\"ADHD\">ADHD</a> by the US <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>.\n</p><p>The use of <a href=\"/wiki/Cholinergic\" title=\"Cholinergic\">cholinergic</a> adjunctive medications is uncommon and their clinical effects are poorly researched;<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup><sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources_(medicine)\" title=\"Wikipedia:Identifying reliable sources (medicine)\"><span title=\"Material near this tag may rely on an unreliable or less reliable medical source. (October 2016)\">unreliable medical source</span></a></i>&#93;</sup><sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup> consequently, cholinergics such as <a href=\"/wiki/Galantamine\" title=\"Galantamine\">galantamine</a> or <a href=\"/wiki/Varenicline\" title=\"Varenicline\">varenicline</a> would be off label use for <a href=\"/wiki/ADHD\" class=\"mw-redirect\" title=\"ADHD\">ADHD</a>.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup><sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup><sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup> New <a href=\"/wiki/Nicotinic_agonist\" title=\"Nicotinic agonist\">nicotinic</a> <a href=\"/wiki/Cholinergic\" title=\"Cholinergic\">cholinergic</a> medications in development for <a href=\"/wiki/ADHD\" class=\"mw-redirect\" title=\"ADHD\">ADHD</a> are <a href=\"/wiki/Pozanicline\" title=\"Pozanicline\">pozanicline</a>,<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup><sup class=\"noprint Inline-Template noprint Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sources\" title=\"Wikipedia:No original research\"><span title=\"Source reports on primary research. Several reviews cite this study, one of those may be more appropriate. (October 2016)\">non-primary source needed</span></a></i>&#93;</sup><sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup> <a href=\"/wiki/ABT-418\" title=\"ABT-418\">ABT-418</a>,<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup><sup class=\"noprint Inline-Template noprint Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sources\" title=\"Wikipedia:No original research\"><span title=\"Source reports on primary research. Several reviews cite this study, one of those may be more appropriate. (October 2016)\">non-primary source needed</span></a></i>&#93;</sup> and <a href=\"/wiki/Nicotinic_agonist\" title=\"Nicotinic agonist\">ABT-894</a>.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup><sup class=\"noprint Inline-Template noprint Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sources\" title=\"Wikipedia:No original research\"><span title=\"Source reports on primary research. Several reviews cite this study, one of those may be more appropriate. (October 2016)\">non-primary source needed</span></a></i>&#93;</sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Prognosis\">Prognosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=6\" title=\"Edit section: Prognosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Self-esteem\">Self-esteem</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=7\" title=\"Edit section: Self-esteem\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In some cases, children who enjoy learning may develop a sense of fear when faced with structured or planned work, especially long or group-based assignments that require extended focus, even if they thoroughly understand the topic. Children with ADHD may be at greater risk of academic failures and early withdrawal from school.<sup id=\"cite_ref-adhd_in_adulthood_25-0\" class=\"reference\"><a href=\"#cite_note-adhd_in_adulthood-25\">&#91;25&#93;</a></sup>  Teachers and parents may make incorrect assumptions about the behaviours and attitudes of a child with ADHD-PI, and may provide them with frequent and erroneous <a href=\"/wiki/Negative_feedback\" title=\"Negative feedback\">negative feedback</a> (e.g. \"careless\", \"you're irresponsible\", \"you're immature\", \"you're lazy\", \"you don't care/show any effort\", \"you just aren't trying\", etc.).<sup id=\"cite_ref-not_lazy_stupid_or_crazy_26-0\" class=\"reference\"><a href=\"#cite_note-not_lazy_stupid_or_crazy-26\">&#91;26&#93;</a></sup>\n</p><p>The inattentive children may realize on some level that they are somehow different internally from their peers. However, they are also likely to accept and internalize the continuous negative feedback, creating a negative <a href=\"/wiki/Self-image\" title=\"Self-image\">self-image</a> that becomes <a href=\"/wiki/Self-reinforcing\" class=\"mw-redirect\" title=\"Self-reinforcing\">self-reinforcing</a>.  If these children progress into adulthood undiagnosed or untreated, their inattentiveness, ongoing frustrations, and poor self-image frequently create numerous and severe problems maintaining healthy relationships, succeeding in <a href=\"/wiki/Postsecondary\" class=\"mw-redirect\" title=\"Postsecondary\">postsecondary</a> schooling, or succeeding in the workplace.  These problems can compound frustrations and low <a href=\"/wiki/Self-esteem\" title=\"Self-esteem\">self-esteem</a>, and will often lead to the development of secondary pathologies including <a href=\"/wiki/Anxiety_disorders\" class=\"mw-redirect\" title=\"Anxiety disorders\">anxiety disorders</a>, <a href=\"/wiki/Mood_disorders\" class=\"mw-redirect\" title=\"Mood disorders\">mood disorders</a>, and <a href=\"/wiki/Substance_abuse\" title=\"Substance abuse\">substance abuse</a>.<sup id=\"cite_ref-adhd_in_adulthood_25-1\" class=\"reference\"><a href=\"#cite_note-adhd_in_adulthood-25\">&#91;25&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Coping_and_age\">Coping and age</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=8\" title=\"Edit section: Coping and age\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>It has been suggested<sup id=\"cite_ref-add_college_5-1\" class=\"reference\"><a href=\"#cite_note-add_college-5\">&#91;5&#93;</a></sup> that some of the symptoms of ADHD present in childhood appear to be less overt in adulthood.  This is likely due to an adult's ability to make <a href=\"/wiki/Cognitive\" class=\"mw-redirect\" title=\"Cognitive\">cognitive</a> adjustments and develop <a href=\"/wiki/Compensation_(psychology)\" title=\"Compensation (psychology)\">compensating</a> or <a href=\"/wiki/Coping_skill\" class=\"mw-redirect\" title=\"Coping skill\">coping skills</a> to minimize the impact of inattentive or hyperactive symptoms. However, the core problems of ADHD do not disappear with age.<sup id=\"cite_ref-adhd_in_adulthood_25-2\" class=\"reference\"><a href=\"#cite_note-adhd_in_adulthood-25\">&#91;25&#93;</a></sup> Some researchers have suggested that individuals with reduced or less overt hyperactivity symptoms should receive the ADHD-combined diagnosis. Hallowell and Ratey (2005) suggest<sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup> that the manifestation of hyperactivity simply changes with adolescence and adulthood, becoming a more generalized restlessness or tendency to fidget.\n</p>\n<h3><span class=\"mw-headline\" id=\"Comparisons_between_subtypes\">Comparisons between subtypes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=9\" title=\"Edit section: Comparisons between subtypes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>A meta-analysis of 37 studies on cognitive differences between those presenting ADHD-Predominantly Inattentive presentations and ADHD-Combined type found that \"the ADHD-C presenting performed better than the ADHD-PI presenting in the areas of processing speed, attention, performance IQ, memory, and fluency. The ADHD-PI presenting performed better than the ADHD-C group on measures of flexibility, working memory, visual/spatial ability, non-verbal IQ, motor ability, and language. Both the ADHD-C and ADHD-PI groups were found to perform more poorly than the control group on measures of inhibition, however, there was no difference found between the two groups. Furthermore, the ADHD-C and ADHD-PI presenting did not differ on measures of sustained attention.\"<sup id=\"cite_ref-Lane,_B._2004_28-0\" class=\"reference\"><a href=\"#cite_note-Lane,_B._2004-28\">&#91;28&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Epidemiology\">Epidemiology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=10\" title=\"Edit section: Epidemiology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>It is difficult to say exactly how many children or adults worldwide have ADHD because different countries have used different ways of diagnosing it, while some do not diagnose it at all. In the UK, diagnosis is based on quite a narrow set of symptoms, and about 0.5\u20131% of children are thought to have attention or hyperactivity problems. In comparison, professionals in the U.S. used a much broader definition of the term ADHD until recently.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (October 2013)\">citation needed</span></a></i>&#93;</sup> This meant up to 10% of children in the U.S. were described as having ADHD. Current estimates suggest that ADHD is present internationally in about 7.2% of children.<sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup> About five times more boys than girls are diagnosed with ADHD. Boys are seen as the prototypical ADHD child, therefore they are more often diagnosed with ADHD than girls.<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup><sup class=\"noprint Inline-Template noprint Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sources\" title=\"Wikipedia:No original research\"><span title=\"Survey research by the authors. (October 2016)\">non-primary source needed</span></a></i>&#93;</sup> This may be partly because of the particular ways they express their difficulties. Boys and girls both have attention problems, but boys are more likely to be overactive and difficult to manage.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (October 2013)\">citation needed</span></a></i>&#93;</sup> Children from all cultures and social groups are diagnosed with ADHD. However, children from certain backgrounds may be particularly likely to be diagnosed with ADHD, because of different expectations about how they should behave.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (October 2013)\">citation needed</span></a></i>&#93;</sup> It is, therefore, important to ensure that a child's cultural background is understood and taken into account as part of the assessment.\n</p>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=11\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In 1980, the <a href=\"/wiki/Diagnostic_and_Statistical_Manual_of_Mental_Disorders#DSM-III_.281980.29\" title=\"Diagnostic and Statistical Manual of Mental Disorders\">DSM-III</a> changed the name of the condition from \"hyperkinetic reaction of childhood\" to \"attention deficit disorder\" (ADD). That happened because research by <a href=\"/wiki/Virginia_Douglas\" title=\"Virginia Douglas\">Virginia Douglas</a> had suggested that the attention deficits were more important than the hyperactive behaviour for understanding the disorder. The new label also reflected the observation of clinicians that attention deficits could also exist without hyperactivity.\n</p><p>For the first time, two subtypes were introduced: ADD with hyperactivity (ADD+H) and ADD without hyperactivity (ADD-H). While the ADD+H category was fairly consistent with previous definitions, the latter subtype represented essentially a new category. Thus, almost everything that is known about the predominantly inattentive subtype is based on research conducted since 1980.<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Attention_deficit_hyperactivity_disorder_predominantly_inattentive&amp;action=edit&amp;section=12\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Weiss, Lawrence G. (2005). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.ca/books?id=Eg9U9e_ICr8C&amp;pg=PA237\"><i>WISC-IV clinical use and interpretation scientist-practitioner perspectives</i></a> (1st ed.). Amsterdam: Elsevier Academic Press. p.&#160;237. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9780125649315\" title=\"Special:BookSources/9780125649315\">9780125649315</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=WISC-IV+clinical+use+and+interpretation+scientist-practitioner+perspectives&amp;rft.place=Amsterdam&amp;rft.pages=237&amp;rft.edition=1st&amp;rft.pub=Elsevier+Academic+Press&amp;rft.date=2005&amp;rft.isbn=9780125649315&amp;rft.aulast=Weiss&amp;rft.aufirst=Lawrence+G.&amp;rft_id=https%3A%2F%2Fbooks.google.ca%2Fbooks%3Fid%3DEg9U9e_ICr8C%26pg%3DPA237&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">American Psychiatric Association (2013). <i>Diagnostic and Statistical Manual of Mental Disorders</i> (5th ed.). Arlington: American Psychiatric Publishing. pp.&#160;59\u201365. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0890425558\" title=\"Special:BookSources/0890425558\">0890425558</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Diagnostic+and+Statistical+Manual+of+Mental+Disorders&amp;rft.place=Arlington&amp;rft.pages=59-65&amp;rft.edition=5th&amp;rft.pub=American+Psychiatric+Publishing&amp;rft.date=2013&amp;rft.isbn=0890425558&amp;rft.au=American+Psychiatric+Association&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Biederman J, Faraone SV, Weber W, Russell RL, Rater M, Park KS (December  1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://business.highbeam.com/5884/article-1G1-20383058/correspondence-between-dsmiiir-and-dsmiv-attentiondeficithyperactivity\">\"Correspondence between DSM-III-R and DSM-IV attention-deficit/hyperactivity disorder\"</a>. <i>Journal of the American Academy of Child and Adolescent Psychiatry</i>. <b>36</b> (12): 1682\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/00004583-199712000-00016\">10.1097/00004583-199712000-00016</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9401329\">9401329</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Academy+of+Child+and+Adolescent+Psychiatry&amp;rft.atitle=Correspondence+between+DSM-III-R+and+DSM-IV+attention-deficit%2Fhyperactivity+disorder&amp;rft.volume=36&amp;rft.issue=12&amp;rft.pages=1682-7&amp;rft.date=1997-12&amp;rft_id=info%3Adoi%2F10.1097%2F00004583-199712000-00016&amp;rft_id=info%3Apmid%2F9401329&amp;rft.aulast=Biederman&amp;rft.aufirst=J&amp;rft.au=Faraone%2C+SV&amp;rft.au=Weber%2C+W&amp;rft.au=Russell%2C+RL&amp;rft.au=Rater%2C+M&amp;rft.au=Park%2C+KS&amp;rft_id=http%3A%2F%2Fbusiness.highbeam.com%2F5884%2Farticle-1G1-20383058%2Fcorrespondence-between-dsmiiir-and-dsmiv-attentiondeficithyperactivity&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lange KW, Reichl S, Lange KM, Tucha L, Tucha O (December  2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907\">\"The history of attention deficit hyperactivity disorder\"</a>. <i>Attention Deficit and Hyperactivity Disorders</i>. <b>2</b> (4): 241\u201355. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s12402-010-0045-8\">10.1007/s12402-010-0045-8</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907\">3000907</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21258430\">21258430</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Attention+Deficit+and+Hyperactivity+Disorders&amp;rft.atitle=The+history+of+attention+deficit+hyperactivity+disorder&amp;rft.volume=2&amp;rft.issue=4&amp;rft.pages=241-55&amp;rft.date=2010-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3000907&amp;rft_id=info%3Apmid%2F21258430&amp;rft_id=info%3Adoi%2F10.1007%2Fs12402-010-0045-8&amp;rft.aulast=Lange&amp;rft.aufirst=KW&amp;rft.au=Reichl%2C+S&amp;rft.au=Lange%2C+KM&amp;rft.au=Tucha%2C+L&amp;rft.au=Tucha%2C+O&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3000907&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-add_college-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-add_college_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-add_college_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Quinn, Patricia (1994). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.maginationpress.com/4416630.html\"><i>ADD and the College Student: A Guide for High School and College Students with Attention Deficit Disorder</i></a>. New York, NY: Magination Press. pp.&#160;2\u20133. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/1-55798-663-0\" title=\"Special:BookSources/1-55798-663-0\">1-55798-663-0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=ADD+and+the+College+Student%3A+A+Guide+for+High+School+and+College+Students+with+Attention+Deficit+Disorder&amp;rft.place=New+York%2C+NY&amp;rft.pages=2-3&amp;rft.pub=Magination+Press&amp;rft.date=1994&amp;rft.isbn=1-55798-663-0&amp;rft.aulast=Quinn&amp;rft.aufirst=Patricia&amp;rft_id=http%3A%2F%2Fwww.maginationpress.com%2F4416630.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://behavenet.com/attention-deficithyperactivity-disorder\">\"Attention-Deficit/Hyperactivity Disorder\"</a>. <i>BehaveNet</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">17 April</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BehaveNet&amp;rft.atitle=Attention-Deficit%2FHyperactivity+Disorder&amp;rft_id=http%3A%2F%2Fbehavenet.com%2Fattention-deficithyperactivity-disorder&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nimh.nih.gov/health/publications/attention-deficit-hyperactivity-disorder/complete-index.shtml\">\"Attention deficit hyperactivity disorder\"</a>. National Institute of Mental health. 2008. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20130119030917/http://www.nimh.nih.gov/health/publications/attention-deficit-hyperactivity-disorder/complete-index.shtml\">Archived</a> from the original on 19 January 2013<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 January</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Attention+deficit+hyperactivity+disorder&amp;rft.pub=National+Institute+of+Mental+health&amp;rft.date=2008&amp;rft_id=http%3A%2F%2Fwww.nimh.nih.gov%2Fhealth%2Fpublications%2Fattention-deficit-hyperactivity-disorder%2Fcomplete-index.shtml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-junginger-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-junginger_8-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Retz W, Retz-Junginger P, Thome J, R\u00f6sler M (September  2011). \"Pharmacological treatment of adult ADHD in Europe\". <i>The World Journal of Biological Psychiatry</i>. <b>12</b> (Suppl 1): 89\u201394. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3109/15622975.2011.603229\">10.3109/15622975.2011.603229</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21906003\">21906003</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+World+Journal+of+Biological+Psychiatry&amp;rft.atitle=Pharmacological+treatment+of+adult+ADHD+in+Europe&amp;rft.volume=12&amp;rft.issue=Suppl+1&amp;rft.pages=89-94&amp;rft.date=2011-09&amp;rft_id=info%3Adoi%2F10.3109%2F15622975.2011.603229&amp;rft_id=info%3Apmid%2F21906003&amp;rft.aulast=Retz&amp;rft.aufirst=W&amp;rft.au=Retz-Junginger%2C+P&amp;rft.au=Thome%2C+J&amp;rft.au=R%C3%B6sler%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-kolar-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-kolar_9-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kolar D, Keller A, Golfinopoulos M, Cumyn L, Syer C, Hechtman L (April  2008). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.dovepress.com/articles.php?article_id=1034\">\"Treatment of adults with attention-deficit/hyperactivity disorder\"</a>. <i>Neuropsychiatric Disease and Treatment</i>. <b>4</b> (2): 389\u2013403. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2518387\">2518387</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18728745\">18728745</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropsychiatric+Disease+and+Treatment&amp;rft.atitle=Treatment+of+adults+with+attention-deficit%2Fhyperactivity+disorder&amp;rft.volume=4&amp;rft.issue=2&amp;rft.pages=389-403&amp;rft.date=2008-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2518387&amp;rft_id=info%3Apmid%2F18728745&amp;rft.aulast=Kolar&amp;rft.aufirst=D&amp;rft.au=Keller%2C+A&amp;rft.au=Golfinopoulos%2C+M&amp;rft.au=Cumyn%2C+L&amp;rft.au=Syer%2C+C&amp;rft.au=Hechtman%2C+L&amp;rft_id=http%3A%2F%2Fwww.dovepress.com%2Farticles.php%3Farticle_id%3D1034&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Volkow, N. D.; Fowler, J. S.; Wang, G.; Ding, Y.; Gatley, S. J. (1 January 2002). \"Mechanism of action of methylphenidate: insights from PET imaging studies\". <i>Journal of Attention Disorders</i>. 6 Suppl 1: S31\u201343. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1087-0547\">1087-0547</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12685517\">12685517</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Attention+Disorders&amp;rft.atitle=Mechanism+of+action+of+methylphenidate%3A+insights+from+PET+imaging+studies&amp;rft.volume=6+Suppl+1&amp;rft.pages=S31-43&amp;rft.date=2002-01-01&amp;rft_id=info%3Apmid%2F12685517&amp;rft.issn=1087-0547&amp;rft.aulast=Volkow&amp;rft.aufirst=N.+D.&amp;rft.au=Fowler%2C+J.+S.&amp;rft.au=Wang%2C+G.&amp;rft.au=Ding%2C+Y.&amp;rft.au=Gatley%2C+S.+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Safety_of_therapeutic_methylphenidate_in_adults:_a_systematic_review_of_the_evidence-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Safety_of_therapeutic_methylphenidate_in_adults:_a_systematic_review_of_the_evidence_11-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Godfrey J (March  2009). \"Safety of therapeutic methylphenidate in adults: a systematic review of the evidence\". <i>Journal of Psychopharmacology</i>. <b>23</b> (2): 194\u2013205. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/0269881108089809\">10.1177/0269881108089809</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18515459\">18515459</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Psychopharmacology&amp;rft.atitle=Safety+of+therapeutic+methylphenidate+in+adults%3A+a+systematic+review+of+the+evidence&amp;rft.volume=23&amp;rft.issue=2&amp;rft.pages=194-205&amp;rft.date=2009-03&amp;rft_id=info%3Adoi%2F10.1177%2F0269881108089809&amp;rft_id=info%3Apmid%2F18515459&amp;rft.au=Godfrey+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-atom-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-atom_12-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Simpson D, Plosker GL (2004). \"Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder\". <i>CNS Drugs</i>. <b>18</b> (6): 397\u2013401. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2165/00023210-200418060-00011\">10.2165/00023210-200418060-00011</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15089111\">15089111</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Spotlight+on+atomoxetine+in+adults+with+attention-deficit+hyperactivity+disorder&amp;rft.volume=18&amp;rft.issue=6&amp;rft.pages=397-401&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.2165%2F00023210-200418060-00011&amp;rft_id=info%3Apmid%2F15089111&amp;rft.aulast=Simpson&amp;rft.aufirst=D&amp;rft.au=Plosker%2C+GL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Messer, Tess (December 2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.primarilyinattentiveadd.com/2009/12/best-medicine-for-inattentive-adhd.html\">\"The Best Medicine for Inattentive ADHD\"</a>. <i>Primarily Inattentive ADHD (blog)</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">25 December</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Primarily+Inattentive+ADHD+%28blog%29&amp;rft.atitle=The+Best+Medicine+for+Inattentive+ADHD&amp;rft.date=2009-12&amp;rft.aulast=Messer&amp;rft.aufirst=Tess&amp;rft_id=http%3A%2F%2Fwww.primarilyinattentiveadd.com%2F2009%2F12%2Fbest-medicine-for-inattentive-adhd.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wilens TE, Decker MW (October  2007). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2974320\">\"Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition\"</a>. <i>Biochemical Pharmacology</i>. <b>74</b> (8): 1212\u201323. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bcp.2007.07.002\">10.1016/j.bcp.2007.07.002</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2974320\">2974320</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17689498\">17689498</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochemical+Pharmacology&amp;rft.atitle=Neuronal+nicotinic+receptor+agonists+for+the+treatment+of+attention-deficit%2Fhyperactivity+disorder%3A+focus+on+cognition&amp;rft.volume=74&amp;rft.issue=8&amp;rft.pages=1212-23&amp;rft.date=2007-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2974320&amp;rft_id=info%3Apmid%2F17689498&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bcp.2007.07.002&amp;rft.aulast=Wilens&amp;rft.aufirst=TE&amp;rft.au=Decker%2C+MW&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2974320&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sarter M, Givens B, Bruno JP (April  2001). \"The cognitive neuroscience of sustained attention: where top-down meets bottom-up\". <i>Brain Research Reviews</i>. <b>35</b> (2): 146\u201360. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0165-0173%2801%2900044-3\">10.1016/S0165-0173(01)00044-3</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11336780\">11336780</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain+Research+Reviews&amp;rft.atitle=The+cognitive+neuroscience+of+sustained+attention%3A+where+top-down+meets+bottom-up&amp;rft.volume=35&amp;rft.issue=2&amp;rft.pages=146-60&amp;rft.date=2001-04&amp;rft_id=info%3Adoi%2F10.1016%2FS0165-0173%2801%2900044-3&amp;rft_id=info%3Apmid%2F11336780&amp;rft.aulast=Sarter&amp;rft.aufirst=M&amp;rft.au=Givens%2C+B&amp;rft.au=Bruno%2C+JP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Levin ED, Simon BB (August  1998). \"Nicotinic acetylcholine involvement in cognitive function in animals\". <i>Psychopharmacology</i>. <b>138</b> (3\u20134): 217\u201330. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s002130050667\">10.1007/s002130050667</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9725745\">9725745</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychopharmacology&amp;rft.atitle=Nicotinic+acetylcholine+involvement+in+cognitive+function+in+animals&amp;rft.volume=138&amp;rft.issue=3%E2%80%934&amp;rft.pages=217-30&amp;rft.date=1998-08&amp;rft_id=info%3Adoi%2F10.1007%2Fs002130050667&amp;rft_id=info%3Apmid%2F9725745&amp;rft.aulast=Levin&amp;rft.aufirst=ED&amp;rft.au=Simon%2C+BB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Demeter E, Sarter M (January  2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3445745\">\"Leveraging the cortical cholinergic system to enhance attention\"</a>. <i>Neuropharmacology</i>. <b>64</b>: 294\u2013304. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.neuropharm.2012.06.060\">10.1016/j.neuropharm.2012.06.060</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3445745\">3445745</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22796110\">22796110</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropharmacology&amp;rft.atitle=Leveraging+the+cortical+cholinergic+system+to+enhance+attention&amp;rft.volume=64&amp;rft.pages=294-304&amp;rft.date=2013-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3445745&amp;rft_id=info%3Apmid%2F22796110&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuropharm.2012.06.060&amp;rft.aulast=Demeter&amp;rft.aufirst=E&amp;rft.au=Sarter%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3445745&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lehmann, Christine (21 November 2003). <a rel=\"nofollow\" class=\"external text\" href=\"http://psychnews.psychiatryonline.org/doi/full/10.1176%2Fpn.38.22.0025\">\"ADHD Symptoms Respond To Cholinergic Drugs\"</a>. <i>Psychiatric News</i>. <b>38</b> (22): 25. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1176/pn.38.22.0025\">10.1176/pn.38.22.0025</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychiatric+News&amp;rft.atitle=ADHD+Symptoms+Respond+To+Cholinergic+Drugs&amp;rft.volume=38&amp;rft.issue=22&amp;rft.pages=25&amp;rft.date=2003-11-21&amp;rft_id=info%3Adoi%2F10.1176%2Fpn.38.22.0025&amp;rft.aulast=Lehmann&amp;rft.aufirst=Christine&amp;rft_id=http%3A%2F%2Fpsychnews.psychiatryonline.org%2Fdoi%2Ffull%2F10.1176%252Fpn.38.22.0025&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Snyder, Bill (11 December 2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.mc.vanderbilt.edu:8080/reporter/index.html?ID=7947\">\"Genetics may explain three types of ADHD\"</a>. <i>Reporter: Vanderbilt University Medical Center's Weekly Newspaper</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Reporter%3A+Vanderbilt+University+Medical+Center%27s+Weekly+Newspaper&amp;rft.atitle=Genetics+may+explain+three+types+of+ADHD&amp;rft.date=2009-12-11&amp;rft.aulast=Snyder&amp;rft.aufirst=Bill&amp;rft_id=http%3A%2F%2Fwww.mc.vanderbilt.edu%3A8080%2Freporter%2Findex.html%3FID%3D7947&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Potter AS, Newhouse PA, Bucci DJ (December  2006). \"Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?\". <i>Behavioural Brain Research</i>. <b>175</b> (2): 201\u201311. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbr.2006.09.015\">10.1016/j.bbr.2006.09.015</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17081628\">17081628</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Behavioural+Brain+Research&amp;rft.atitle=Central+nicotinic+cholinergic+systems%3A+a+role+in+the+cognitive+dysfunction+in+attention-deficit%2Fhyperactivity+disorder%3F&amp;rft.volume=175&amp;rft.issue=2&amp;rft.pages=201-11&amp;rft.date=2006-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbr.2006.09.015&amp;rft_id=info%3Apmid%2F17081628&amp;rft.aulast=Potter&amp;rft.aufirst=AS&amp;rft.au=Newhouse%2C+PA&amp;rft.au=Bucci%2C+DJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Apostol G, Abi-Saab W, Kratochvil CJ, Adler LA, Robieson WZ, Gault LM, Pritchett YL, Feifel D, Collins MA, Saltarelli MD (February  2012). \"Efficacy and safety of the novel \u03b1\u2084\u03b2\u2082 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study\". <i>Psychopharmacology</i>. <b>219</b> (3): 715\u201325. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00213-011-2393-2\">10.1007/s00213-011-2393-2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21748252\">21748252</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychopharmacology&amp;rft.atitle=Efficacy+and+safety+of+the+novel+%CE%B1%E2%82%84%CE%B2%E2%82%82+neuronal+nicotinic+receptor+partial+agonist+ABT-089+in+adults+with+attention-deficit%2Fhyperactivity+disorder%3A+a+randomized%2C+double-blind%2C+placebo-controlled+crossover+study&amp;rft.volume=219&amp;rft.issue=3&amp;rft.pages=715-25&amp;rft.date=2012-02&amp;rft_id=info%3Adoi%2F10.1007%2Fs00213-011-2393-2&amp;rft_id=info%3Apmid%2F21748252&amp;rft.aulast=Apostol&amp;rft.aufirst=G&amp;rft.au=Abi-Saab%2C+W&amp;rft.au=Kratochvil%2C+CJ&amp;rft.au=Adler%2C+LA&amp;rft.au=Robieson%2C+WZ&amp;rft.au=Gault%2C+LM&amp;rft.au=Pritchett%2C+YL&amp;rft.au=Feifel%2C+D&amp;rft.au=Collins%2C+MA&amp;rft.au=Saltarelli%2C+MD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rueter LE, Anderson DJ, Briggs CA, Donnelly-Roberts DL, Gintant GA, Gopalakrishnan M, Lin NH, Osinski MA, Reinhart GA, Buckley MJ, Martin RL, McDermott JS, Preusser LC, Seifert TR, Su Z, Cox BF, Decker MW, Sullivan JP (2004). \"ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders\". <i>CNS Drug Reviews</i>. <b>10</b> (2): 167\u201382. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1527-3458.2004.tb00011.x\">10.1111/j.1527-3458.2004.tb00011.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15179445\">15179445</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drug+Reviews&amp;rft.atitle=ABT-089%3A+pharmacological+properties+of+a+neuronal+nicotinic+acetylcholine+receptor+agonist+for+the+potential+treatment+of+cognitive+disorders&amp;rft.volume=10&amp;rft.issue=2&amp;rft.pages=167-82&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1527-3458.2004.tb00011.x&amp;rft_id=info%3Apmid%2F15179445&amp;rft.aulast=Rueter&amp;rft.aufirst=LE&amp;rft.au=Anderson%2C+DJ&amp;rft.au=Briggs%2C+CA&amp;rft.au=Donnelly-Roberts%2C+DL&amp;rft.au=Gintant%2C+GA&amp;rft.au=Gopalakrishnan%2C+M&amp;rft.au=Lin%2C+NH&amp;rft.au=Osinski%2C+MA&amp;rft.au=Reinhart%2C+GA&amp;rft.au=Buckley%2C+MJ&amp;rft.au=Martin%2C+RL&amp;rft.au=McDermott%2C+JS&amp;rft.au=Preusser%2C+LC&amp;rft.au=Seifert%2C+TR&amp;rft.au=Su%2C+Z&amp;rft.au=Cox%2C+BF&amp;rft.au=Decker%2C+MW&amp;rft.au=Sullivan%2C+JP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wilens TE, Biederman J, Spencer TJ, Bostic J, Prince J, Monuteaux MC, Soriano J, Fine C, Abrams A, Rater M, Polisner D (December  1999). <a rel=\"nofollow\" class=\"external text\" href=\"http://ajp.psychiatryonline.org/article.aspx?volume=156&amp;page=1931\">\"A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder\"</a>. <i>The American Journal of Psychiatry</i>. <b>156</b> (12): 1931\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1176/ajp.156.12.1931\">10.1176/ajp.156.12.1931</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10588407\">10588407</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.atitle=A+pilot+controlled+clinical+trial+of+ABT-418%2C+a+cholinergic+agonist%2C+in+the+treatment+of+adults+with+attention+deficit+hyperactivity+disorder&amp;rft.volume=156&amp;rft.issue=12&amp;rft.pages=1931-7&amp;rft.date=1999-12&amp;rft_id=info%3Adoi%2F10.1176%2Fajp.156.12.1931&amp;rft_id=info%3Apmid%2F10588407&amp;rft.aulast=Wilens&amp;rft.aufirst=TE&amp;rft.au=Biederman%2C+J&amp;rft.au=Spencer%2C+TJ&amp;rft.au=Bostic%2C+J&amp;rft.au=Prince%2C+J&amp;rft.au=Monuteaux%2C+MC&amp;rft.au=Soriano%2C+J&amp;rft.au=Fine%2C+C&amp;rft.au=Abrams%2C+A&amp;rft.au=Rater%2C+M&amp;rft.au=Polisner%2C+D&amp;rft_id=http%3A%2F%2Fajp.psychiatryonline.org%2Farticle.aspx%3Fvolume%3D156%26page%3D1931&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bain EE, Robieson W, Pritchett Y, Garimella T, Abi-Saab W, Apostol G, McGough JJ, Saltarelli MD (February  2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3547191\">\"A randomized, double-blind, placebo-controlled phase 2 study of \u03b14\u03b22 agonist ABT-894 in adults with ADHD\"</a>. <i>Neuropsychopharmacology</i>. <b>38</b> (3): 405\u201313. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/npp.2012.194\">10.1038/npp.2012.194</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3547191\">3547191</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23032073\">23032073</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.atitle=A+randomized%2C+double-blind%2C+placebo-controlled+phase+2+study+of+%CE%B14%CE%B22+agonist+ABT-894+in+adults+with+ADHD&amp;rft.volume=38&amp;rft.issue=3&amp;rft.pages=405-13&amp;rft.date=2013-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3547191&amp;rft_id=info%3Apmid%2F23032073&amp;rft_id=info%3Adoi%2F10.1038%2Fnpp.2012.194&amp;rft.aulast=Bain&amp;rft.aufirst=EE&amp;rft.au=Robieson%2C+W&amp;rft.au=Pritchett%2C+Y&amp;rft.au=Garimella%2C+T&amp;rft.au=Abi-Saab%2C+W&amp;rft.au=Apostol%2C+G&amp;rft.au=McGough%2C+JJ&amp;rft.au=Saltarelli%2C+MD&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3547191&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-adhd_in_adulthood-25\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-adhd_in_adulthood_25-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-adhd_in_adulthood_25-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-adhd_in_adulthood_25-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Triolo, Santo (1998). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ilab.org/db/detail.php?booknr=338314075\"><i>Attention Deficit Hyperactivity Disorder in Adulthood: A Practitioner's Handbook</i></a>. Philadelphia, PA: Brunner-Routledge. pp.&#160;65\u201369. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-87630-890-6\" title=\"Special:BookSources/0-87630-890-6\">0-87630-890-6</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Attention+Deficit+Hyperactivity+Disorder+in+Adulthood%3A+A+Practitioner%27s+Handbook&amp;rft.place=Philadelphia%2C+PA&amp;rft.pages=65-69&amp;rft.pub=Brunner-Routledge&amp;rft.date=1998&amp;rft.isbn=0-87630-890-6&amp;rft.aulast=Triolo&amp;rft.aufirst=Santo&amp;rft_id=http%3A%2F%2Fwww.ilab.org%2Fdb%2Fdetail.php%3Fbooknr%3D338314075&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-not_lazy_stupid_or_crazy-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-not_lazy_stupid_or_crazy_26-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Kelly, Kate; Ramundo, Peggy (2006). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.simonsays.com/content/book.cfm?tab=1&amp;pid=506364\"><i>You Mean I'm Not Lazy, Stupid or Crazy?! The Classic Self-Help Book For Adults with Attention Deficit Disorder</i></a>. New York, NY: Scribner. pp.&#160;11\u201312. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-7432-6448-7\" title=\"Special:BookSources/0-7432-6448-7\">0-7432-6448-7</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=You+Mean+I%27m+Not+Lazy%2C+Stupid+or+Crazy%3F%21+The+Classic+Self-Help+Book+For+Adults+with+Attention+Deficit+Disorder&amp;rft.place=New+York%2C+NY&amp;rft.pages=11-12&amp;rft.pub=Scribner&amp;rft.date=2006&amp;rft.isbn=0-7432-6448-7&amp;rft.aulast=Kelly&amp;rft.aufirst=Kate&amp;rft.au=Ramundo%2C+Peggy&amp;rft_id=http%3A%2F%2Fwww.simonsays.com%2Fcontent%2Fbook.cfm%3Ftab%3D1%26pid%3D506364&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\"><a href=\"/wiki/Edward_Hallowell_(psychiatrist)\" title=\"Edward Hallowell (psychiatrist)\">Hallowell, Edward M.</a>; <a href=\"/wiki/John_Ratey\" title=\"John Ratey\">Ratey, John J.</a> (2005). <i><a href=\"/wiki/Delivered_from_Distraction\" class=\"mw-redirect\" title=\"Delivered from Distraction\">Delivered from Distraction: Getting the Most out of Life with Attention Deficit Disorder</a></i>. New York: Ballantine Books. pp.&#160;253\u20135. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-345-44231-8\" title=\"Special:BookSources/0-345-44231-8\">0-345-44231-8</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Delivered+from+Distraction%3A+Getting+the+Most+out+of+Life+with+Attention+Deficit+Disorder&amp;rft.place=New+York&amp;rft.pages=253-5&amp;rft.pub=Ballantine+Books&amp;rft.date=2005&amp;rft.isbn=0-345-44231-8&amp;rft.aulast=Hallowell&amp;rft.aufirst=Edward+M.&amp;rft.au=Ratey%2C+John+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Lane,_B._2004-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Lane,_B._2004_28-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Lane, Brittany Ann (2003). <i>The differential neuropsychological/cognitive profiles of ADHD presentations: A meta-analysis</i> (PhD Thesis). University of Northern Colorado. <a href=\"/wiki/OCLC\" title=\"OCLC\">OCLC</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/oclc/56479200\">56479200</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+differential+neuropsychological%2Fcognitive+profiles+of+ADHD+presentations%3A+A+meta-analysis&amp;rft.pub=University+of+Northern+Colorado&amp;rft.date=2003&amp;rft_id=info%3Aoclcnum%2F56479200&amp;rft.aulast=Lane&amp;rft.aufirst=Brittany+Ann&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\"><span title=\"This citation requires a reference to the specific page or range of pages in which the material appears. (September 2014)\">page&#160;needed</span></a></i>&#93;</sup></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Thomas, Rae; Sanders, Sharon; Doust, Jenny; Beller, Elaine; Glasziou, Paul (2015-04-01). <a rel=\"nofollow\" class=\"external text\" href=\"http://pediatrics.aappublications.org/content/135/4/e994\">\"Prevalence of Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis\"</a>. <i>Pediatrics</i>. <b>135</b> (4): e994\u2013e1001. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1542/peds.2014-3482\">10.1542/peds.2014-3482</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0031-4005\">0031-4005</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25733754\">25733754</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatrics&amp;rft.atitle=Prevalence+of+Attention-Deficit%2FHyperactivity+Disorder%3A+A+Systematic+Review+and+Meta-analysis&amp;rft.volume=135&amp;rft.issue=4&amp;rft.pages=e994-e1001&amp;rft.date=2015-04-01&amp;rft.issn=0031-4005&amp;rft_id=info%3Apmid%2F25733754&amp;rft_id=info%3Adoi%2F10.1542%2Fpeds.2014-3482&amp;rft.aulast=Thomas&amp;rft.aufirst=Rae&amp;rft.au=Sanders%2C+Sharon&amp;rft.au=Doust%2C+Jenny&amp;rft.au=Beller%2C+Elaine&amp;rft.au=Glasziou%2C+Paul&amp;rft_id=http%3A%2F%2Fpediatrics.aappublications.org%2Fcontent%2F135%2F4%2Fe994&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bruchm\u00fcller K, Margraf J, Schneider S (February  2012). \"Is ADHD diagnosed in accord with diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis\". <i>Journal of Consulting and Clinical Psychology</i>. <b>80</b> (1): 128\u201338. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1037/a0026582\">10.1037/a0026582</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22201328\">22201328</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Consulting+and+Clinical+Psychology&amp;rft.atitle=Is+ADHD+diagnosed+in+accord+with+diagnostic+criteria%3F+Overdiagnosis+and+influence+of+client+gender+on+diagnosis&amp;rft.volume=80&amp;rft.issue=1&amp;rft.pages=128-38&amp;rft.date=2012-02&amp;rft_id=info%3Adoi%2F10.1037%2Fa0026582&amp;rft_id=info%3Apmid%2F22201328&amp;rft.aulast=Bruchm%C3%BCller&amp;rft.aufirst=K&amp;rft.au=Margraf%2C+J&amp;rft.au=Schneider%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Wheeler, Jennifer; Carlson, Caryn (3 July 1996). <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20160706111707/http://www.kidsource.com/LDA-CA/ADD_WO.html\">\"Attention Deficit Disorder without Hyperactivity (ADHD, Predominantly Inattentive Type)\"</a>. <i>KidSource Online</i>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.kidsource.com/LDA-CA/ADD_WO.html\">the original</a> on 6 July 2016<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">30 June</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=KidSource+Online&amp;rft.atitle=Attention+Deficit+Disorder+without+Hyperactivity+%28ADHD%2C+Predominantly+Inattentive+Type%29&amp;rft.date=1996-07-03&amp;rft.aulast=Wheeler&amp;rft.aufirst=Jennifer&amp;rft.au=Carlson%2C+Caryn&amp;rft_id=http%3A%2F%2Fwww.kidsource.com%2FLDA-CA%2FADD_WO.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAttention+deficit+hyperactivity+disorder+predominantly+inattentive\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<table role=\"presentation\" class=\"mbox-small plainlinks sistersitebox\" style=\"background-color:#f9f9f9;border:1px solid #aaa;color:#000\">\n<tbody><tr>\n<td class=\"mbox-image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/40px-Wiktionary-logo-en-v2.svg.png\" width=\"40\" height=\"40\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/60px-Wiktionary-logo-en-v2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/80px-Wiktionary-logo-en-v2.svg.png 2x\" data-file-width=\"512\" data-file-height=\"512\" /></td>\n<td class=\"mbox-text plainlist\">Look up <i><b><a href=\"https://en.wiktionary.org/wiki/ADHD-PI\" class=\"extiw\" title=\"wiktionary:ADHD-PI\">ADHD-PI</a></b></i>&#160;or <i><b><a href=\"https://en.wiktionary.org/wiki/ADHD\" class=\"extiw\" title=\"wiktionary:ADHD\">ADHD</a></b></i> in Wiktionary, the free dictionary.</td></tr></tbody></table>\n<table role=\"presentation\" class=\"mbox-small plainlinks sistersitebox\" style=\"background-color:#f9f9f9;border:1px solid #aaa;color:#000\">\n<tbody><tr>\n<td class=\"mbox-image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png\" width=\"30\" height=\"40\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x\" data-file-width=\"1024\" data-file-height=\"1376\" /></td>\n<td class=\"mbox-text plainlist\">Wikimedia Commons has media related to <i><b><a href=\"https://commons.wikimedia.org/wiki/Category:Attention_Deficit_Hyperactivity_Disorder\" class=\"extiw\" title=\"commons:Category:Attention Deficit Hyperactivity Disorder\">Attention Deficit Hyperactivity Disorder</a></b></i>.</td></tr></tbody></table>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Attention_deficit_hyperactivity_disorder_(F90,_314)\" style=\"padding:3px\"><table class=\"nowraplinks collapsible expanded navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Attention-deficit_hyperactivity_disorder\" title=\"Template:Attention-deficit hyperactivity disorder\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Attention-deficit_hyperactivity_disorder\" title=\"Template talk:Attention-deficit hyperactivity disorder\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Attention-deficit_hyperactivity_disorder&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Attention_deficit_hyperactivity_disorder_(F90,_314)\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Attention_deficit_hyperactivity_disorder\" title=\"Attention deficit hyperactivity disorder\">Attention deficit hyperactivity disorder</a> (<a href=\"/wiki/ICD-10_Chapter_V:_Mental_and_behavioural_disorders#(F90\u2013F98)_Behavioural_and_emotional_disorders_with_onset_usually_occurring_in_childhood_and_adolescence\" title=\"ICD-10 Chapter V: Mental and behavioural disorders\">F90</a>, <a href=\"/wiki/List_of_ICD-9_codes_290%E2%80%93319:_mental_disorders#Mental_disorders_diagnosed_in_childhood\" title=\"List of ICD-9 codes 290\u2013319: mental disorders\">314</a>)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Main articles</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/History_of_attention_deficit_hyperactivity_disorder\" title=\"History of attention deficit hyperactivity disorder\">History of ADHD</a></li>\n<li><a href=\"/wiki/Adult_attention_deficit_hyperactivity_disorder\" title=\"Adult attention deficit hyperactivity disorder\">ADHD in adults</a></li>\n<li><a href=\"/wiki/Attention_deficit_hyperactivity_disorder_controversies\" title=\"Attention deficit hyperactivity disorder controversies\">ADHD controversies</a></li>\n<li><a href=\"/wiki/Attention_deficit_hyperactivity_disorder_management\" title=\"Attention deficit hyperactivity disorder management\">ADHD management</a></li>\n<li><a href=\"/wiki/Social_construct_theory_of_ADHD\" title=\"Social construct theory of ADHD\">Social construct theory of ADHD</a></li>\n<li><a href=\"/wiki/Coaching#ADHD_coaching\" title=\"Coaching\">ADHD coaching</a></li>\n<li><a href=\"/wiki/Epidemiology_of_attention_deficit_hyperactive_disorder\" title=\"Epidemiology of attention deficit hyperactive disorder\">Epidemiology of ADHD</a></li>\n<li><a href=\"/wiki/Diet_and_attention_deficit_hyperactivity_disorder\" title=\"Diet and attention deficit hyperactivity disorder\">Diet and ADHD</a></li></ul>\n<ul><li><i>Major characteristics:</i> <a href=\"/wiki/Attention\" title=\"Attention\">Attention</a></li>\n<li><a href=\"/wiki/Hyperactivity\" class=\"mw-redirect\" title=\"Hyperactivity\">Hyperactivity</a></li>\n<li><a href=\"/wiki/Impulsivity\" title=\"Impulsivity\">Impulsivity</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Sub-types</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a class=\"mw-selflink selflink\">ADHD predominantly inattentive</a> (ADHD-I, formerly <b>ADD</b>)</li>\n<li><a href=\"/wiki/Attention_deficit_hyperactivity_disorder\" title=\"Attention deficit hyperactivity disorder\">ADHD predominantly hyperactive</a> (ADHD-H, formerly <b>ADHD</b>)</li>\n<li><a href=\"/wiki/Attention_deficit_hyperactivity_disorder\" title=\"Attention deficit hyperactivity disorder\">ADHD combined type</a> (ADHD-C)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Notable <a href=\"/wiki/Category:Publications_about_attention_deficit_hyperactivity_disorder\" title=\"Category:Publications about attention deficit hyperactivity disorder\">publications</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/Driven_to_Distraction_(1994)\" class=\"mw-redirect\" title=\"Driven to Distraction (1994)\">Driven to Distraction</a></i> (1994)</li>\n<li><i><a href=\"/wiki/Delivered_from_Distraction\" class=\"mw-redirect\" title=\"Delivered from Distraction\">Delivered from Distraction</a></i> (2005)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Attention_deficit_hyperactivity_disorder_management#Medications\" title=\"Attention deficit hyperactivity disorder management\">Medications</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<dl><dd><i>Stimulants:</i></dd></dl>\n<ul><li><a href=\"/wiki/Methylphenidate\" title=\"Methylphenidate\">Methylphenidate</a> (Ritalin, Concerta, and others)</li>\n<li><a href=\"/wiki/Dexmethylphenidate\" title=\"Dexmethylphenidate\">Dexmethylphenidate</a> (Focalin, Focalin XR)</li>\n<li><a href=\"/wiki/Amphetamine\" title=\"Amphetamine\">Amphetamine</a> (Evekeo, <a href=\"/wiki/Adderall\" title=\"Adderall\">Adderall</a>, Adzenys XR, Dyanavel XR)</li>\n<li><a href=\"/wiki/Dextroamphetamine\" title=\"Dextroamphetamine\">Dextroamphetamine</a> (Dexedrine, Zenzedi, ProCentra, and others)</li>\n<li><a href=\"/wiki/Lisdexamfetamine\" title=\"Lisdexamfetamine\">Lisdexamfetamine</a> (Vyvanse)</li></ul>\n<dl><dd><i>Non-stimulant:</i></dd></dl>\n<ul><li><a href=\"/wiki/Atomoxetine\" title=\"Atomoxetine\">Atomoxetine</a> (Strattera)</li>\n<li><a href=\"/wiki/Guanfacine\" title=\"Guanfacine\">Guanfacine</a> (Tenex <i>(off-label)</i>, Intuniv)</li>\n<li><a href=\"/wiki/Clonidine\" title=\"Clonidine\">Clonidine</a> (Catapres <i>(off-label)</i>, Kapvay)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Related or outdated topics</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Auditory_processing_disorder\" title=\"Auditory processing disorder\">Auditory processing disorder</a></li>\n<li><a href=\"/wiki/Deficits_in_attention,_motor_control_and_perception\" title=\"Deficits in attention, motor control and perception\">Deficits in attention, motor control and perception</a></li>\n<li><a href=\"/wiki/Developmental_coordination_disorder\" title=\"Developmental coordination disorder\">Developmental coordination disorder</a></li>\n<li><a href=\"/wiki/Low_arousal_theory\" title=\"Low arousal theory\">Low arousal theory</a></li>\n<li><a href=\"/wiki/Sluggish_cognitive_tempo\" title=\"Sluggish cognitive tempo\">Sluggish cognitive tempo</a></li>\n<li><a href=\"/wiki/Sensory_processing_disorder\" title=\"Sensory processing disorder\">Sensory processing disorder</a></li>\n<li><a href=\"/wiki/Hunter_vs._farmer_hypothesis\" title=\"Hunter vs. farmer hypothesis\">Hunter vs. farmer hypothesis</a></li></ul>\n</div></td></tr><tr><td class=\"navbox-abovebelow hlist\" colspan=\"2\"><div>\n<ul><li><img alt=\"Category\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png\" title=\"Category\" width=\"16\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/24px-Folder_Hexagonal_Icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/32px-Folder_Hexagonal_Icon.svg.png 2x\" data-file-width=\"36\" data-file-height=\"31\" /> <a href=\"/wiki/Category:Attention-deficit_hyperactivity_disorder\" title=\"Category:Attention-deficit hyperactivity disorder\">Category</a></li>\n<li><img alt=\"Portal\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/16px-Portal-puzzle.svg.png\" title=\"Portal\" width=\"16\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/24px-Portal-puzzle.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/32px-Portal-puzzle.svg.png 2x\" data-file-width=\"32\" data-file-height=\"28\" /> <a href=\"/wiki/Portal:Attention-deficit_hyperactivity_disorder\" title=\"Portal:Attention-deficit hyperactivity disorder\">Portal</a></li></ul>\n</div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Amphetamine\" style=\"padding:3px\"><table class=\"nowraplinks collapsible collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Amphetamine\" title=\"Template:Amphetamine\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Amphetamine\" title=\"Template talk:Amphetamine\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Amphetamine&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Amphetamine\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Amphetamine\" title=\"Amphetamine\">Amphetamine</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: center\">Main articles <br />and <br />pharmaceuticals</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:10.5em\"><a href=\"/wiki/Amphetamine\" title=\"Amphetamine\">Amphetamine</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Adzenys XR-ODT</i></li>\n<li><i>Dyanavel XR</i></li>\n<li><i>Evekeo</i></li>\n<li>Mixed amphetamine salts\n<ul><li><i><a href=\"/wiki/Adderall\" title=\"Adderall\">Adderall</a></i></li>\n<li><i>Adderall XR</i></li>\n<li><i>Mydayis</i></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:10.5em\"><a href=\"/wiki/Levoamphetamine\" title=\"Levoamphetamine\">Levoamphetamine</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">N/A</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:10.5em\"><a href=\"/wiki/Dextroamphetamine\" title=\"Dextroamphetamine\">Dextroamphetamine</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Dexedrine</i></li>\n<li><i>ProCentra</i></li>\n<li><i>Zenzedi</i></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:10.5em\"><a href=\"/wiki/Lisdexamfetamine\" title=\"Lisdexamfetamine\">Lisdexamfetamine</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>Vyvanse</i></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: center\">Neuropharmacology</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:10.5em\"><a href=\"/wiki/Biomolecular_target\" class=\"mw-redirect\" title=\"Biomolecular target\">Biomolecular targets</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/TAAR1\" title=\"TAAR1\">TAAR1</a> (<a href=\"/wiki/Agonist#Types_of_agonists\" title=\"Agonist\">full agonist</a>)</li>\n<li><a href=\"/wiki/Cocaine_and_amphetamine_regulated_transcript\" title=\"Cocaine and amphetamine regulated transcript\">CART</a> (<a href=\"/wiki/Messenger_RNA\" title=\"Messenger RNA\"><abbr title=\"messenger RNA\">mRNA</abbr></a> inducer)</li>\n<li><a href=\"/wiki/5-HT1A_receptor\" title=\"5-HT1A receptor\">5-HT1A receptor</a> (low affinity <a href=\"/wiki/Ligand_(biochemistry)\" title=\"Ligand (biochemistry)\">ligand</a>)</li>\n<li><a href=\"/wiki/Monoamine_oxidase\" title=\"Monoamine oxidase\">MAO</a> (weak <a href=\"/wiki/Competitive_inhibition\" title=\"Competitive inhibition\">competitive inhibitor</a>)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:10.5em\">Inhibited <a href=\"/wiki/Membrane_transport_protein\" title=\"Membrane transport protein\">transporters</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Dopamine_transporter\" title=\"Dopamine transporter\">DAT</a></li>\n<li><a href=\"/wiki/Norepinephrine_transporter\" title=\"Norepinephrine transporter\">NET</a></li>\n<li><a href=\"/wiki/Serotonin_transporter\" title=\"Serotonin transporter\">SERT</a></li>\n<li><a href=\"/wiki/Vesicular_monoamine_transporter_1\" title=\"Vesicular monoamine transporter 1\">VMAT1</a></li>\n<li><a href=\"/wiki/Vesicular_monoamine_transporter_2\" title=\"Vesicular monoamine transporter 2\">VMAT2</a></li>\n<li><a href=\"/wiki/Glutamate_transporter#EAATs\" title=\"Glutamate transporter\">EAAT3</a></li>\n<li><a href=\"/wiki/SLC22A3\" title=\"SLC22A3\">SLC22A3</a></li>\n<li><a href=\"/wiki/SLC22A5\" title=\"SLC22A5\">SLC22A5</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: center\">Active metabolites</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/4-Hydroxyamphetamine\" title=\"4-Hydroxyamphetamine\">4-Hydroxyamphetamine</a></li>\n<li><a href=\"/wiki/P-Hydroxynorephedrine\" title=\"P-Hydroxynorephedrine\">4-Hydroxynorephedrine</a></li>\n<li><a href=\"/wiki/Phenylpropanolamine\" title=\"Phenylpropanolamine\">Norephedrine</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: center\">Related articles</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Attention_deficit_hyperactivity_disorder\" title=\"Attention deficit hyperactivity disorder\">ADHD</a></li>\n<li><a href=\"/wiki/Attention_deficit_hyperactivity_disorder_management\" title=\"Attention deficit hyperactivity disorder management\">ADHD management</a></li>\n<li><a href=\"/wiki/Stimulant_psychosis#Substituted_amphetamines\" title=\"Stimulant psychosis\">Amphetamine psychosis</a></li>\n<li><a href=\"/wiki/Dopamine\" title=\"Dopamine\">Dopamine</a></li>\n<li><a href=\"/wiki/Doping_in_sport\" title=\"Doping in sport\">Doping in sport</a></li>\n<li><a href=\"/wiki/Executive_functions\" title=\"Executive functions\">Executive functions</a></li>\n<li><a href=\"/wiki/Formetorex\" title=\"Formetorex\">Formetorex</a></li>\n<li><a href=\"/wiki/FOSB#\u0394FosB\" title=\"FOSB\">\u0394FosB</a></li>\n<li><a href=\"/wiki/History_and_culture_of_substituted_amphetamines\" title=\"History and culture of substituted amphetamines\">History and culture of substituted amphetamines</a></li>\n<li><a href=\"/wiki/History_of_Benzedrine\" title=\"History of Benzedrine\">History of Benzedrine</a></li>\n<li><a href=\"/wiki/Methamphetamine\" title=\"Methamphetamine\">Methamphetamine</a></li>\n<li><a href=\"/wiki/Methylphenidate\" title=\"Methylphenidate\">Methylphenidate</a></li>\n<li><a href=\"/wiki/N-Methylphenethylamine\" title=\"N-Methylphenethylamine\"><i>N</i>-Methylphenethylamine</a></li>\n<li><a href=\"/wiki/Motivational_salience\" title=\"Motivational salience\">Motivational salience</a>\n<ul><li><a href=\"/wiki/Motivational_salience#Incentive_salience\" title=\"Motivational salience\">Incentive salience</a></li></ul></li>\n<li><a href=\"/wiki/Narcolepsy\" title=\"Narcolepsy\">Narcolepsy</a></li>\n<li><a href=\"/wiki/Neurobiological_effects_of_physical_exercise#Attention_deficit_hyperactivity_disorder\" title=\"Neurobiological effects of physical exercise\">Neurobiological effects of physical exercise \u00a7&#160;Attention deficit hyperactivity disorder</a></li>\n<li><a href=\"/wiki/Nootropic\" title=\"Nootropic\">Nootropic</a></li>\n<li><a href=\"/wiki/Norepinephrine\" title=\"Norepinephrine\">Norepinephrine</a></li>\n<li><a href=\"/wiki/Obesity\" title=\"Obesity\">Obesity</a></li>\n<li><a href=\"/wiki/Performance-enhancing_substance\" title=\"Performance-enhancing substance\">Performance-enhancing substance</a></li>\n<li><a href=\"/wiki/Phenethylamine\" title=\"Phenethylamine\">Phenethylamine</a></li>\n<li><a href=\"/wiki/Phentermine\" title=\"Phentermine\">Phentermine</a></li>\n<li><a href=\"/wiki/Phenylacetone\" title=\"Phenylacetone\">Phenylacetone</a></li>\n<li><a href=\"/wiki/Recreational_drug_use\" title=\"Recreational drug use\">Recreational drug use</a></li>\n<li><a href=\"/wiki/Serotonin\" title=\"Serotonin\">Serotonin</a></li>\n<li><a href=\"/wiki/Substituted_amphetamine\" title=\"Substituted amphetamine\">Substituted amphetamine</a></li>\n<li><a href=\"/wiki/Trace_amine\" title=\"Trace amine\">Trace amine</a></li></ul>\n</div></td></tr><tr><td class=\"navbox-abovebelow hlist\" colspan=\"2\"><div>\n<ul><li><img alt=\"Category\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png\" title=\"Category\" width=\"16\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/24px-Folder_Hexagonal_Icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/32px-Folder_Hexagonal_Icon.svg.png 2x\" data-file-width=\"36\" data-file-height=\"31\" /> <a href=\"/wiki/Category:Amphetamine\" title=\"Category:Amphetamine\">Category</a></li>\n<li><img alt=\"Portal\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/16px-Portal-puzzle.svg.png\" title=\"Portal\" width=\"16\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/24px-Portal-puzzle.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fd/Portal-puzzle.svg/32px-Portal-puzzle.svg.png 2x\" data-file-width=\"32\" data-file-height=\"28\" /> <a href=\"/wiki/Portal:Amphetamine\" title=\"Portal:Amphetamine\">Portal</a></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2250\nCached time: 20180919115952\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.660 seconds\nReal time usage: 0.768 seconds\nPreprocessor visited node count: 3820/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 146695/2097152 bytes\nTemplate argument size: 8042/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 7/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 49397/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.353/10.000 seconds\nLua memory usage: 6.19 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  663.986      1 -total\n 39.38%  261.451      1 Template:Reflist\n 18.64%  123.737     11 Template:Fix\n 17.45%  115.844      1 Template:Infobox_medical_condition\n 17.32%  114.991     19 Template:Cite_journal\n 11.13%   73.921      1 Template:Infobox\n 10.58%   70.252     11 Template:Delink\n  9.84%   65.351      4 Template:Citation_needed\n  9.10%   60.434      7 Template:Cite_book\n  7.76%   51.518      4 Template:Navbox\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:4081458-0!canonical and timestamp 20180919115952 and revision id 860028931\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%A7%D8%B6%D8%B7%D8%B1%D8%A7%D8%A8_%D9%81%D8%B1%D8%B7_%D8%A7%D9%84%D9%86%D8%B4%D8%A7%D8%B7_%D9%88%D9%86%D9%82%D8%B5_%D8%A7%D9%84%D8%A7%D9%86%D8%AA%D8%A8%D8%A7%D9%87_(%D8%A7%D9%84%D8%BA%D9%81%D9%84%D8%A9_%D8%A7%D9%84%D8%B3%D8%A7%D8%A6%D8%AF%D8%A9)","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0627\u0636\u0637\u0631\u0627\u0628 \u0641\u0631\u0637 \u0627\u0644\u0646\u0634\u0627\u0637 \u0648\u0646\u0642\u0635 \u0627\u0644\u0627\u0646\u062a\u0628\u0627\u0647 (\u0627\u0644\u063a\u0641\u0644\u0629 \u0627\u0644\u0633\u0627\u0626\u062f\u0629)"},{"lang":"eo","url":"https://eo.wikipedia.org/wiki/Atentomanka-hiperaktiva_perturbo_precipe_neatenta","langname":"Esperanto","autonym":"Esperanto","*":"Atentomanka-hiperaktiva perturbo precipe neatenta"},{"lang":"fy","url":"https://fy.wikipedia.org/wiki/Attention_deficit_disorder","langname":"Western Frisian","autonym":"Frysk","*":"Attention deficit disorder"},{"lang":"he","url":"https://he.wikipedia.org/wiki/%D7%94%D7%A4%D7%A8%D7%A2%D7%AA_%D7%A7%D7%A9%D7%91,_%D7%A8%D7%99%D7%9B%D7%95%D7%96_%D7%95%D7%94%D7%99%D7%A4%D7%A8%D7%90%D7%A7%D7%98%D7%99%D7%91%D7%99%D7%95%D7%AA_%D7%94%D7%9E%D7%90%D7%95%D7%A4%D7%99%D7%99%D7%A0%D7%AA_%D7%91%D7%A2%D7%99%D7%A7%D7%A8_%D7%91%D7%A7%D7%A9%D7%99%D7%99_%D7%A7%D7%A9%D7%91","langname":"Hebrew","autonym":"\u05e2\u05d1\u05e8\u05d9\u05ea","*":"\u05d4\u05e4\u05e8\u05e2\u05ea \u05e7\u05e9\u05d1, \u05e8\u05d9\u05db\u05d5\u05d6 \u05d5\u05d4\u05d9\u05e4\u05e8\u05d0\u05e7\u05d8\u05d9\u05d1\u05d9\u05d5\u05ea \u05d4\u05de\u05d0\u05d5\u05e4\u05d9\u05d9\u05e0\u05ea \u05d1\u05e2\u05d9\u05e7\u05e8 \u05d1\u05e7\u05e9\u05d9\u05d9 \u05e7\u05e9\u05d1"},{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Aandachtstekortstoornis","langname":"Dutch","autonym":"Nederlands","*":"Aandachtstekortstoornis"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Dist%C3%BArbio_do_d%C3%A9ficit_de_aten%C3%A7%C3%A3o_sem_hiperatividade","langname":"Portuguese","autonym":"portugu\u00eas","*":"Dist\u00farbio do d\u00e9ficit de aten\u00e7\u00e3o sem hiperatividade"}],"categories":[{"sortkey":"","hidden":"","*":"Wikipedia_articles_needing_page_number_citations_from_September_2014"},{"sortkey":"","hidden":"","*":"Use_dmy_dates_from_April_2015"},{"sortkey":"","hidden":"","*":"Infobox_medical_condition"},{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_October_2016"},{"sortkey":"","hidden":"","*":"Articles_needing_additional_references_from_October_2016"},{"sortkey":"","hidden":"","*":"All_articles_needing_additional_references"},{"sortkey":"","hidden":"","*":"Articles_using_small_message_boxes"},{"sortkey":"","hidden":"","*":"All_articles_lacking_reliable_references"},{"sortkey":"","hidden":"","*":"Articles_lacking_reliable_references_from_October_2016"},{"sortkey":"","hidden":"","*":"All_pages_needing_factual_verification"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_needing_factual_verification_from_October_2016"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_October_2013"},{"sortkey":"","*":"Attention_deficit_hyperactivity_disorder"},{"sortkey":"","*":"Amphetamine"}],"links":[{"ns":14,"exists":"","*":"Category:Use dmy dates from April 2015"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from October 2016"},{"ns":14,"exists":"","*":"Category:Articles needing additional references from October 2016"},{"ns":14,"exists":"","*":"Category:Articles lacking reliable references from October 2016"},{"ns":14,"exists":"","*":"Category:Wikipedia articles needing factual verification from October 2016"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from October 2013"},{"ns":14,"exists":"","*":"Category:Wikipedia articles needing page number citations from September 2014"},{"ns":14,"exists":"","*":"Category:Amphetamine"},{"ns":14,"exists":"","*":"Category:Attention-deficit hyperactivity disorder"},{"ns":14,"exists":"","*":"Category:Publications about attention deficit hyperactivity disorder"},{"ns":10,"exists":"","*":"Template:Attention-deficit hyperactivity disorder"},{"ns":10,"exists":"","*":"Template:Amphetamine"},{"ns":0,"exists":"","*":"4-Hydroxyamphetamine"},{"ns":0,"exists":"","*":"5-HT1A receptor"},{"ns":0,"exists":"","*":"ABT-418"},{"ns":0,"exists":"","*":"ADHD"},{"ns":0,"exists":"","*":"Adderall"},{"ns":0,"exists":"","*":"Adult attention deficit hyperactivity disorder"},{"ns":0,"exists":"","*":"Agonist"},{"ns":0,"exists":"","*":"Amphetamine"},{"ns":0,"exists":"","*":"Amphetamine mixed salts (medication)"},{"ns":0,"exists":"","*":"Anxiety disorder"},{"ns":0,"exists":"","*":"Anxiety disorders"},{"ns":0,"exists":"","*":"Atomoxetine"},{"ns":0,"exists":"","*":"Attention"},{"ns":0,"exists":"","*":"Attention deficit hyperactivity disorder"},{"ns":0,"exists":"","*":"Attention deficit hyperactivity disorder controversies"},{"ns":0,"exists":"","*":"Attention deficit hyperactivity disorder management"},{"ns":0,"exists":"","*":"Attentional control"},{"ns":0,"exists":"","*":"Auditory processing disorder"},{"ns":0,"exists":"","*":"Biomolecular target"},{"ns":0,"exists":"","*":"Cardiovascular disease"},{"ns":0,"exists":"","*":"Cholinergic"},{"ns":0,"exists":"","*":"Clonidine"},{"ns":0,"exists":"","*":"Coaching"},{"ns":0,"exists":"","*":"Cocaine and amphetamine regulated transcript"},{"ns":0,"exists":"","*":"Cognitive"},{"ns":0,"exists":"","*":"Cognitive inhibition"},{"ns":0,"exists":"","*":"Compensation (psychology)"},{"ns":0,"exists":"","*":"Competitive inhibition"},{"ns":0,"exists":"","*":"Coping (psychology)"},{"ns":0,"exists":"","*":"Coping skill"},{"ns":0,"exists":"","*":"DSM-5"},{"ns":0,"exists":"","*":"Daydreaming"},{"ns":0,"exists":"","*":"Deficits in attention, motor control and perception"},{"ns":0,"exists":"","*":"Delivered from Distraction"},{"ns":0,"exists":"","*":"Developmental coordination disorder"},{"ns":0,"exists":"","*":"Dexmethylphenidate"},{"ns":0,"exists":"","*":"Dextroamphetamine"},{"ns":0,"exists":"","*":"Diagnostic and Statistical Manual of Mental Disorders"},{"ns":0,"exists":"","*":"Diet and attention deficit hyperactivity disorder"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Directed attention fatigue"},{"ns":0,"exists":"","*":"Dissociative disorder"},{"ns":0,"exists":"","*":"Dopamine"},{"ns":0,"exists":"","*":"Dopamine reuptake inhibitor"},{"ns":0,"exists":"","*":"Dopamine transporter"},{"ns":0,"exists":"","*":"Doping in sport"},{"ns":0,"exists":"","*":"Driven to Distraction (1994)"},{"ns":0,"exists":"","*":"Edward Hallowell (psychiatrist)"},{"ns":0,"exists":"","*":"Epidemiology of attention deficit hyperactive disorder"},{"ns":0,"exists":"","*":"Executive functions"},{"ns":0,"exists":"","*":"FOSB"},{"ns":0,"exists":"","*":"Fatigue (medical)"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Formetorex"},{"ns":0,"exists":"","*":"Galantamine"},{"ns":0,"exists":"","*":"Glutamate transporter"},{"ns":0,"exists":"","*":"Guanfacine"},{"ns":0,"exists":"","*":"History and culture of substituted amphetamines"},{"ns":0,"exists":"","*":"History of Benzedrine"},{"ns":0,"exists":"","*":"History of attention deficit hyperactivity disorder"},{"ns":0,"exists":"","*":"Human multitasking"},{"ns":0,"exists":"","*":"Hunter vs. farmer hypothesis"},{"ns":0,"exists":"","*":"Hyperactivity"},{"ns":0,"exists":"","*":"ICD-10 Chapter V: Mental and behavioural disorders"},{"ns":0,"exists":"","*":"Impulsivity"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"Intrusive thoughts"},{"ns":0,"exists":"","*":"John Ratey"},{"ns":0,"exists":"","*":"Levoamphetamine"},{"ns":0,"exists":"","*":"Ligand (biochemistry)"},{"ns":0,"exists":"","*":"Lisdexamfetamine"},{"ns":0,"exists":"","*":"List of ICD-9 codes 290\u2013319: mental disorders"},{"ns":0,"exists":"","*":"Low arousal theory"},{"ns":0,"exists":"","*":"Membrane transport protein"},{"ns":0,"exists":"","*":"Messenger RNA"},{"ns":0,"exists":"","*":"Methamphetamine"},{"ns":0,"exists":"","*":"Methylphenidate"},{"ns":0,"exists":"","*":"Mixed Amphetamine Salts"},{"ns":0,"exists":"","*":"Monoamine oxidase"},{"ns":0,"exists":"","*":"Mood disorder"},{"ns":0,"exists":"","*":"Mood disorders"},{"ns":0,"exists":"","*":"Motivational salience"},{"ns":0,"exists":"","*":"N-Methylphenethylamine"},{"ns":0,"exists":"","*":"Narcolepsy"},{"ns":0,"exists":"","*":"Negative feedback"},{"ns":0,"exists":"","*":"Neurobiological effects of physical exercise"},{"ns":0,"exists":"","*":"Nicotinic agonist"},{"ns":0,"exists":"","*":"Nootropic"},{"ns":0,"exists":"","*":"Norepinephrine"},{"ns":0,"exists":"","*":"Norepinephrine reuptake inhibitor"},{"ns":0,"exists":"","*":"Norepinephrine transporter"},{"ns":0,"exists":"","*":"OCLC"},{"ns":0,"exists":"","*":"Obesity"},{"ns":0,"exists":"","*":"P-Hydroxynorephedrine"},{"ns":0,"exists":"","*":"Performance-enhancing substance"},{"ns":0,"exists":"","*":"Personality disorder"},{"ns":0,"exists":"","*":"Pervasive developmental disorder"},{"ns":0,"exists":"","*":"Phenethylamine"},{"ns":0,"exists":"","*":"Phentermine"},{"ns":0,"exists":"","*":"Phenylacetone"},{"ns":0,"exists":"","*":"Phenylpropanolamine"},{"ns":0,"exists":"","*":"Postsecondary"},{"ns":0,"exists":"","*":"Pozanicline"},{"ns":0,"exists":"","*":"Procrastination"},{"ns":0,"exists":"","*":"Psychotic disorder"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Recall (memory)"},{"ns":0,"exists":"","*":"Recreational drug use"},{"ns":0,"exists":"","*":"SLC22A3"},{"ns":0,"exists":"","*":"SLC22A5"},{"ns":0,"exists":"","*":"Schizophrenia"},{"ns":0,"exists":"","*":"Self-esteem"},{"ns":0,"exists":"","*":"Self-image"},{"ns":0,"exists":"","*":"Self-reinforcing"},{"ns":0,"exists":"","*":"Sensory processing disorder"},{"ns":0,"exists":"","*":"Serotonin"},{"ns":0,"exists":"","*":"Serotonin transporter"},{"ns":0,"exists":"","*":"Sluggish cognitive tempo"},{"ns":0,"exists":"","*":"Social construct theory of ADHD"},{"ns":0,"exists":"","*":"Stimulant psychosis"},{"ns":0,"exists":"","*":"Substance abuse"},{"ns":0,"exists":"","*":"Substituted amphetamine"},{"ns":0,"exists":"","*":"Synaptic cleft"},{"ns":0,"exists":"","*":"TAAR1"},{"ns":0,"exists":"","*":"Trace amine"},{"ns":0,"exists":"","*":"Trace amine associated receptor 1"},{"ns":0,"exists":"","*":"Varenicline"},{"ns":0,"exists":"","*":"Vesicular monoamine transporter 1"},{"ns":0,"exists":"","*":"Vesicular monoamine transporter 2"},{"ns":0,"exists":"","*":"Vigilance (psychology)"},{"ns":0,"exists":"","*":"Virginia Douglas"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Identifying reliable sources (medicine)"},{"ns":4,"exists":"","*":"Wikipedia:No original research"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":11,"exists":"","*":"Template talk:Amphetamine"},{"ns":11,"exists":"","*":"Template talk:Attention-deficit hyperactivity disorder"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"},{"ns":100,"exists":"","*":"Portal:Amphetamine"},{"ns":100,"exists":"","*":"Portal:Attention-deficit hyperactivity disorder"}],"templates":[{"ns":10,"exists":"","*":"Template:Bots"},{"ns":10,"exists":"","*":"Template:Use dmy dates"},{"ns":10,"exists":"","*":"Template:DMCA"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":10,"exists":"","*":"Template:Infobox medical condition"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Comma separated entries"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Unreferenced section"},{"ns":10,"exists":"","*":"Template:Unreferenced"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Main"},{"ns":10,"exists":"","*":"Template:Unreliable medical source"},{"ns":10,"exists":"","*":"Template:Primary source inline"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Page needed"},{"ns":10,"exists":"","*":"Template:Wiktionary"},{"ns":10,"exists":"","*":"Template:Sister project"},{"ns":10,"exists":"","*":"Template:Side box"},{"ns":10,"exists":"","*":"Template:Commons category"},{"ns":10,"exists":"","*":"Template:Commons"},{"ns":10,"exists":"","*":"Template:Adhd"},{"ns":10,"exists":"","*":"Template:Attention-deficit hyperactivity disorder"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Icon"},{"ns":10,"exists":"","*":"Template:Amphetamine"},{"ns":10,"exists":"","*":"Template:Abbrlink"},{"ns":10,"exists":"","*":"Template:Abbr"},{"ns":10,"exists":"","*":"Template:If pagename"},{"ns":10,"exists":"","*":"Template:When pagename is"},{"ns":10,"exists":"","*":"Template:Section link"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Ns has subpages"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:Separated entries"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Wikidata"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:Infobox/i18n"},{"ns":828,"exists":"","*":"Module:Wikidata/i18n"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Math"},{"ns":828,"exists":"","*":"Module:ParameterCount"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Main"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Side box"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Icon"},{"ns":828,"exists":"","*":"Module:Icon/data"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Section link"}],"images":["Lock-green.svg","Question_book-new.svg","Wiktionary-logo-en-v2.svg","Commons-logo.svg","Folder_Hexagonal_Icon.svg","Portal-puzzle.svg"],"externallinks":["https://books.google.ca/books?id=Eg9U9e_ICr8C&pg=PA237","http://business.highbeam.com/5884/article-1G1-20383058/correspondence-between-dsmiiir-and-dsmiv-attentiondeficithyperactivity","//doi.org/10.1097/00004583-199712000-00016","//www.ncbi.nlm.nih.gov/pubmed/9401329","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3000907","//doi.org/10.1007/s12402-010-0045-8","//www.ncbi.nlm.nih.gov/pubmed/21258430","http://www.maginationpress.com/4416630.html","http://behavenet.com/attention-deficithyperactivity-disorder","http://www.nimh.nih.gov/health/publications/attention-deficit-hyperactivity-disorder/complete-index.shtml","https://web.archive.org/web/20130119030917/http://www.nimh.nih.gov/health/publications/attention-deficit-hyperactivity-disorder/complete-index.shtml","//doi.org/10.3109/15622975.2011.603229","//www.ncbi.nlm.nih.gov/pubmed/21906003","http://www.dovepress.com/articles.php?article_id=1034","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2518387","//www.ncbi.nlm.nih.gov/pubmed/18728745","//www.worldcat.org/issn/1087-0547","//www.ncbi.nlm.nih.gov/pubmed/12685517","//doi.org/10.1177/0269881108089809","//www.ncbi.nlm.nih.gov/pubmed/18515459","//doi.org/10.2165/00023210-200418060-00011","//www.ncbi.nlm.nih.gov/pubmed/15089111","http://www.primarilyinattentiveadd.com/2009/12/best-medicine-for-inattentive-adhd.html","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2974320","//doi.org/10.1016/j.bcp.2007.07.002","//www.ncbi.nlm.nih.gov/pubmed/17689498","//doi.org/10.1016/S0165-0173(01)00044-3","//www.ncbi.nlm.nih.gov/pubmed/11336780","//doi.org/10.1007/s002130050667","//www.ncbi.nlm.nih.gov/pubmed/9725745","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3445745","//doi.org/10.1016/j.neuropharm.2012.06.060","//www.ncbi.nlm.nih.gov/pubmed/22796110","http://psychnews.psychiatryonline.org/doi/full/10.1176%2Fpn.38.22.0025","//doi.org/10.1176/pn.38.22.0025","http://www.mc.vanderbilt.edu:8080/reporter/index.html?ID=7947","//doi.org/10.1016/j.bbr.2006.09.015","//www.ncbi.nlm.nih.gov/pubmed/17081628","//doi.org/10.1007/s00213-011-2393-2","//www.ncbi.nlm.nih.gov/pubmed/21748252","//doi.org/10.1111/j.1527-3458.2004.tb00011.x","//www.ncbi.nlm.nih.gov/pubmed/15179445","http://ajp.psychiatryonline.org/article.aspx?volume=156&page=1931","//doi.org/10.1176/ajp.156.12.1931","//www.ncbi.nlm.nih.gov/pubmed/10588407","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3547191","//doi.org/10.1038/npp.2012.194","//www.ncbi.nlm.nih.gov/pubmed/23032073","http://www.ilab.org/db/detail.php?booknr=338314075","http://www.simonsays.com/content/book.cfm?tab=1&pid=506364","//www.worldcat.org/oclc/56479200","http://pediatrics.aappublications.org/content/135/4/e994","//doi.org/10.1542/peds.2014-3482","//www.worldcat.org/issn/0031-4005","//www.ncbi.nlm.nih.gov/pubmed/25733754","//doi.org/10.1037/a0026582","//www.ncbi.nlm.nih.gov/pubmed/22201328","https://web.archive.org/web/20160706111707/http://www.kidsource.com/LDA-CA/ADD_WO.html","http://www.kidsource.com/LDA-CA/ADD_WO.html"],"sections":[{"toclevel":1,"level":"2","line":"Classification","number":"1","index":"1","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":2910,"anchor":"Classification"},{"toclevel":1,"level":"2","line":"Signs and symptoms","number":"2","index":"2","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":3511,"anchor":"Signs_and_symptoms"},{"toclevel":2,"level":"3","line":"DSM-5 criteria","number":"2.1","index":"3","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":3535,"anchor":"DSM-5_criteria"},{"toclevel":1,"level":"2","line":"Treatment","number":"3","index":"4","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":8266,"anchor":"Treatment"},{"toclevel":2,"level":"3","line":"Medication","number":"3.1","index":"5","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":9042,"anchor":"Medication"},{"toclevel":1,"level":"2","line":"Prognosis","number":"4","index":"6","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":17362,"anchor":"Prognosis"},{"toclevel":2,"level":"3","line":"Self-esteem","number":"4.1","index":"7","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":17377,"anchor":"Self-esteem"},{"toclevel":2,"level":"3","line":"Coping and age","number":"4.2","index":"8","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":19613,"anchor":"Coping_and_age"},{"toclevel":2,"level":"3","line":"Comparisons between subtypes","number":"4.3","index":"9","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":20782,"anchor":"Comparisons_between_subtypes"},{"toclevel":1,"level":"2","line":"Epidemiology","number":"5","index":"10","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":21880,"anchor":"Epidemiology"},{"toclevel":1,"level":"2","line":"History","number":"6","index":"11","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":24270,"anchor":"History"},{"toclevel":1,"level":"2","line":"References","number":"7","index":"12","fromtitle":"Attention_deficit_hyperactivity_disorder_predominantly_inattentive","byteoffset":25629,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Attention deficit hyperactivity disorder predominantly inattentive","iwlinks":[{"prefix":"d","url":"https://www.wikidata.org/wiki/Q1993146","*":"d:Q1993146"},{"prefix":"wiktionary","url":"https://en.wiktionary.org/wiki/ADHD-PI","*":"wiktionary:ADHD-PI"},{"prefix":"wiktionary","url":"https://en.wiktionary.org/wiki/ADHD","*":"wiktionary:ADHD"},{"prefix":"commons","url":"https://commons.wikimedia.org/wiki/Category:Attention_Deficit_Hyperactivity_Disorder","*":"commons:Category:Attention Deficit Hyperactivity Disorder"}],"properties":[{"name":"wikibase_item","*":"Q1993146"}]}}